1.ZQK at $5.78 on 1/14/2013; here is the company info Quiksilver, Inc. designs, develops, produces, and distributes apparel, footwear, accessories, and related products.
Update on 12/27/2013 : todays price of ZQK is $8.51 we made 47% profit
1/30/2013 price is $6.41
2. MSON Price on 12/11/2012 – $7.49
Link to quote for MSON
This develops ultrasonic medical device products. Used in surgical procedures. I always like medical companies with innovative solutions. The one I made some money few years ago was ISRG which had a good run. I think this is the bottom of the market trading less than $8 and should be a good buy. May be some other big company will buy this one.
1/30 price is 7.82 –> sell
3. TROV – 5.73 dated 12/13/2012
This is a speculative stock; it can go either way big; can go to zero or give you good run like VRUS gave me last year ($7 to $140)
This is a a development stage molecular diagnostic company, focuses on developing and marketing urine-based nucleic acid tests for patient/disease screening and monitoring.
TROV update; todays price as of 1/15/2013 is $8.54 almost 50% return on the money; sell some and keep some for free (take out your cost with selling some portion)
4. SGMO dated 1/15/2013 Price $8.23
clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins
Update: SGMO price as of 1/30 is $9.54
Price as of 12/30/2013 is $14.04 –> sell some and get money back
5. BLRX added on 1/30/2013
BLRX price is $4.55
quote here http://finance.yahoo.com/q?s=blrx&ql=1
clinical stage biopharmaceutical development company, together with its subsidiaries, engages in identifying, in-licensing, and developing therapeutic candidates. Sell and make this break even
6. ACPW added on 2/7/2013
Active Power, Inc., together with its subsidiaries, designs, manufactures, and markets critical power quality solutions. It provides various products that deliver continuous clean power; and protects customers from voltage fluctuation. Sell it at a slight loss and get out
iCAD, Inc. provides image analysis and workflow solutions that enable radiologists and other healthcare professionals to identify pathologies and pinpoint cancer earlier
Anything medical related which improves efficiency and reduce cost is a good investment.
Price on 2/14/2013 is $6.24
12/30/2013 price is $11.68; keep 50% and sell remaining 50%; now you own this stock for free